We inaugurated the future and brought realities together with our Biotec

December 19, 2016

On November 25th, we inaugurated the first plant in Brazil for monoclonal biosimilar medicines, to be produced on industrial scale. Through a productive development partnership (PDP), entered with the Brazilian Government, this technology may be transferred to Instituto Butantan, expanding the population’s access to the latest treatments for different types of cancer and autoimmune diseases.

 

Click here for more information and see the photos of the event.

If you are interested, you can watch the solemnity video on our Facebook page.

 

Share